These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38903942)
1. Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines. Wang Y; Wei X; Liu Y; Li S; Pan W; Dai J; Yang Z Front Cell Infect Microbiol; 2024; 14():1412478. PubMed ID: 38903942 [TBL] [Abstract][Full Text] [Related]
2. A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice. Chaparian RR; Harding AT; Hamele CE; Riebe K; Karlsson A; Sempowski GD; Heaton NS; Heaton BE J Virol; 2022 Aug; 96(15):e0068922. PubMed ID: 35862698 [TBL] [Abstract][Full Text] [Related]
4. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351 [TBL] [Abstract][Full Text] [Related]
5. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses. Sinha D; Yaugel-Novoa M; Waeckel L; Paul S; Longet S Antiviral Res; 2024 Mar; 223():105823. PubMed ID: 38331200 [TBL] [Abstract][Full Text] [Related]
6. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection. Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551 [TBL] [Abstract][Full Text] [Related]
7. Progress in the development of virus-like particle vaccines against respiratory viruses. Quan FS; Basak S; Chu KB; Kim SS; Kang SM Expert Rev Vaccines; 2020 Jan; 19(1):11-24. PubMed ID: 31903811 [No Abstract] [Full Text] [Related]
8. A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections. Wu N; Zhang J; Shen Y; Zhang X; Zhou J; Wu Y; Li E; Meng X; Chuai X; Chiu S; Wang Y Mol Ther; 2024 Apr; 32(4):1033-1047. PubMed ID: 38341613 [TBL] [Abstract][Full Text] [Related]
9. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge. Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602 [TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus vaccines: an update on those in the immediate pipeline. Esposito S; Di Pietro G Future Microbiol; 2016 Oct; 11():1479-1490. PubMed ID: 27750448 [TBL] [Abstract][Full Text] [Related]
11. Current progress on development of respiratory syncytial virus vaccine. Chang J BMB Rep; 2011 Apr; 44(4):232-7. PubMed ID: 21524347 [TBL] [Abstract][Full Text] [Related]
12. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Taleb SA; Al Thani AA; Al Ansari K; Yassine HM Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1817-1827. PubMed ID: 29876771 [TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385 [TBL] [Abstract][Full Text] [Related]
14. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease. Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586 [TBL] [Abstract][Full Text] [Related]
15. Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin. Lee YN; Hwang HS; Kim MC; Lee YT; Kim YJ; Lee FE; Kang SM Nanomedicine; 2016 Apr; 12(3):759-770. PubMed ID: 26656630 [TBL] [Abstract][Full Text] [Related]
16. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy. Beeler JA; Eichelberger MC Microb Pathog; 2013 Feb; 55():9-15. PubMed ID: 23247146 [TBL] [Abstract][Full Text] [Related]